Invention Grant
![N-[(pyrimidinylamino)propanyl]-,n-[pyridylamino)propanyl]- and n-[(pyrazinylaminol)propanyl]arylcarboxamides](/docs/US/2022-02-01/US11236072B2/abs.jpg.600x600.jpg)
- Patent Title: N-[(pyrimidinylamino)propanyl]-,n-[pyridylamino)propanyl]- and n-[(pyrazinylaminol)propanyl]arylcarboxamides
-
Application No.: US16634890Application Date: 2018-07-26
-
Publication No.: US11236072B2Publication Date: 2022-02-01
- Inventor: Doris Riether , Marco Ferrara , Niklas Heine , Uta Friederike Lessel , Radoslaw Lipinski , Stefan Scheuerer
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent David L. Kershner
- Priority: EP17183978 20170731
- International Application: PCT/EP2018/070267 WO 20180726
- International Announcement: WO2019/025275 WO 20190207
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D401/14 ; C07D403/12
![N-[(pyrimidinylamino)propanyl]-,n-[pyridylamino)propanyl]- and n-[(pyrazinylaminol)propanyl]arylcarboxamides](/abs-image/US/2022/02/01/US11236072B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to novel N-[(Pyrimidinylamino)propanyl]-, N-[(Pyridylamino)-propanyl]- and N-[(Pyrazinylamino)¬propanyl]arylcarboxamide such as compound The present invention also relates to derivatives of such compounds, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment or prevention of conditions having an association with the orexin sub-type 1 receptor.
Public/Granted literature
Information query
